Literature DB >> 11309555

Preventing drug interactions by online prescription screening in community pharmacies and medical practices.

H Halkin1, I Katzir, I Kurman, J Jan, B B Malkin.   

Abstract

BACKGROUND: Drug interactions have been shown to be preventable by computerized prescription entry and screening only in hospitals and not in community-based practice.
METHODS: We retrospectively evaluated the effect of online prescription screening in community pharmacies and physician offices of one health maintenance organization, phased in during 3 consecutive 6-month periods in 1998 to 1999 (period I, system active only in 40% of pharmacies; period II, system active in 90% of pharmacies and 50% of physician offices; period III, system active in 95% of pharmacies and 90% of physician practices), on rates of prescriptions with-, patient exposure to-, and physician prescribing of-potential drug interactions.
FINDINGS: Cumulative data included 775,186 patients given at least one prescription, by one or more of 5504 physicians, whose prescriptions were dispensed at 572 pharmacies. Dispensing of drug interaction prescriptions was reduced by 21.1% and by 67.5% in periods II and III compared with period I (odds ratio, 0.79; 95% confidence limit, 0.75-0.83 and odds ratio, 0.28; 95% confidence limit, 0.26-0.30, respectively). Patient exposure decreased only in those receiving 3 to 7 concurrent drugs (odds ratio, 0.80; 95% confidence limit, 0.71-0.90) with no reductions for patients who were given 2 drugs or 8 or more drugs. Only 19% to 25% of physicians wrote prescriptions for drugs that interact, but 85% of these repeated this pattern after being alerted. The proportion of prescriptions of drugs that interact that originated with a single prescriber, as opposed to 2 prescribers, decreased during the 3 periods from 0.81 to 0.74 and 0.69 (P <.001).
INTERPRETATION: Computerized prescription entry and drug interaction screening in the community caused a 62.8% reduction in pharmacy-dispensed prescriptions with severe drug interactions and a 20% reduction in patient exposure to prescriptions with severe drug interactions; this reduction was negated by polypharmacy of 8 or more drugs. The effect of interaction alerts on physician prescribing patterns was limited.

Entities:  

Mesh:

Year:  2001        PMID: 11309555     DOI: 10.1067/mcp.2001.114228

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  28 in total

1.  Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in Germany.

Authors:  Verena Bergk; Christiane Gasse; Rainer Schnell; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2004-09-04       Impact factor: 2.953

Review 2.  Potential determinants of drug-drug interaction associated dispensing in community pharmacies.

Authors:  Matthijs L Becker; Marjon Kallewaard; Peter W J Caspers; Tom Schalekamp; Bruno H C Stricker
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Clinical relevance of drug-drug interactions : a structured assessment procedure.

Authors:  Eric N van Roon; Sander Flikweert; Marianne le Comte; Pim N J Langendijk; Wilma J M Kwee-Zuiderwijk; Paul Smits; Jacobus R B J Brouwers
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Use of an online surveillance system for screening drug interactions in prescriptions in community pharmacies.

Authors:  Tiina Heikkilä; Tuula Lekander; Hannu Raunio
Journal:  Eur J Clin Pharmacol       Date:  2006-06-22       Impact factor: 2.953

5.  Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions.

Authors:  Henk Buurma; Peter A G M De Smet; Antoine C G Egberts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 6.  Clinical risk management of herb-drug interactions.

Authors:  Peter A G M De Smet
Journal:  Br J Clin Pharmacol       Date:  2006-11-20       Impact factor: 4.335

7.  Management of potential drug interactions in community pharmacies: a questionnaire-based survey in Switzerland.

Authors:  Jörg Indermitte; Laura Erba; Marianne Beutler; Rudolf Bruppacher; Walter E Haefeli; Kurt E Hersberger
Journal:  Eur J Clin Pharmacol       Date:  2007-01-11       Impact factor: 2.953

8.  Evaluation of drug-drug interaction screening software combined with pharmacist intervention.

Authors:  Cristiano S Moura; Nília M Prado; Najara O Belo; Francisco A Acurcio
Journal:  Int J Clin Pharm       Date:  2012-04-26

9.  Towards improving dose administration aid supply: a quality improvement intervention aimed at reducing dispensing errors.

Authors:  Julia Fiona-Maree Gilmartin; Jennifer Lillian Marriott; Safeera Yasmeen Hussainy
Journal:  Int J Clin Pharm       Date:  2013-08-23

10.  Coadministration of co-trimoxazole with sulfonylureas: hypoglycemia events and pattern of use.

Authors:  Alai Tan; Holly M Holmes; Yong-Fang Kuo; Mukaila A Raji; James S Goodwin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05-24       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.